Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Offer for Subscription - Update

4 Aug 2021 15:30

RNS Number : 6032H
Amati AIM VCT PLC
04 August 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Amati AIM VCT plc

4 August 2021

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Offer for subscription - Update

The Board of Amati AIM VCT plc (the "Company") announced on 28 July 2021 that the Company had published a prospectus (the "Prospectus") in connection with proposals to raise up to £40 million (with an over-allotment facility to raise up to a further £25 million), by way of an offer for subscription of new ordinary shares (the "Offer") (the "New Shares").

The Board has been advised that, on the basis of applications received, the Company has successfully raised £40 million under the Offer. The Board does not intend to utilise the over-allotment facility at the current time, but the Investment Manager is closely monitoring potential investment opportunities and, if it is felt appropriate, the Company will seek to raise further funds under the over-allotment facility prior to the Offer closing.

The first allotment of New Shares is expected to be on or around 9 August 2021. Dealings in the New Shares issued under this allotment are expected to become effective on 23 August 2021. The Company is no longer accepting applications in relation to the Offer. Investors whose applications are received after the Company raised £40 million will have their subscription monies returned in accordance with the terms and conditions of the Offer. If the over-allotment facility is to be utilised, the Company will make a further RNS announcement detailing the application process.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUBPRUPGGCC
Date   Source Headline
8th Jan 20209:52 amRNSHolding(s) in Company
3rd Jan 20208:01 amRNSTotal Voting Rights
3rd Jan 20207:57 amRNSNet Asset Value(s)
20th Dec 20193:14 pmRNSNet Asset Value(s)
16th Dec 201912:09 pmRNSNet Asset Value(s)
10th Dec 20192:54 pmRNSTransaction in Own Shares
10th Dec 201912:16 pmRNSDirector/PDMR Shareholding
10th Dec 201912:08 pmRNSIssue of Equity
9th Dec 201910:06 amRNSNet Asset Value(s)
2nd Dec 20194:44 pmRNSNet Asset Value(s)
2nd Dec 20192:44 pmRNSTransaction in Own Shares
2nd Dec 201910:13 amRNSTotal Voting Rights
26th Nov 20192:43 pmRNSDirector/PDMR Shareholding
26th Nov 201912:39 pmRNSIssue of Equity
25th Nov 20192:34 pmRNSTransaction in Own Shares
22nd Nov 20195:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20194:05 pmRNSIssue of Equity
22nd Nov 20191:40 pmRNSNet Asset Value(s)
22nd Nov 20197:00 amRNSHolding(s) in Company
18th Nov 20193:51 pmRNSTransaction in Own Shares
18th Nov 201911:53 amRNSNet Asset Value(s)
8th Nov 20195:24 pmRNSNet Asset Value(s)
4th Nov 201911:54 amRNSNet Asset Value(s)
1st Nov 20199:34 amRNSTotal Voting Rights
31st Oct 20195:02 pmRNSOffer for subscription
28th Oct 201912:25 pmRNSTransaction in Own Shares
28th Oct 201911:50 amRNSNet Asset Value(s)
18th Oct 20194:16 pmRNSNet Asset Value(s)
16th Oct 201911:29 amRNSTransaction in Own Shares
16th Oct 201910:23 amRNSNet Asset Value(s)
8th Oct 20192:07 pmRNSHalf-year Report
8th Oct 20191:33 pmRNSDividend Declaration
7th Oct 201910:09 amRNSNet Asset Value(s)
1st Oct 20195:20 pmRNSNet Asset Value(s)
1st Oct 20199:20 amRNSTotal Voting Rights
25th Sep 20192:41 pmRNSTransaction in Own Shares
20th Sep 20194:41 pmRNSNet Asset Value(s)
17th Sep 201910:22 amRNSTransaction in Own Shares
16th Sep 20193:25 pmRNSNet Asset Value(s)
10th Sep 20191:08 pmRNSTransaction in Own Shares
6th Sep 20195:34 pmRNSNet Asset Value(s)
2nd Sep 20195:18 pmRNSNet Asset Value(s)
2nd Sep 20198:05 amRNSTotal Voting Rights
30th Aug 20196:17 pmRNSHolding(s) in Company
28th Aug 20197:00 amRNSUpdate on offer for subscription
27th Aug 20192:27 pmRNSNet Asset Value(s)
23rd Aug 20191:41 pmRNSTransaction in Own Shares
20th Aug 20192:33 pmRNSTransaction in Own Shares
19th Aug 20192:06 pmRNSNet Asset Value(s)
15th Aug 20195:17 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.